20/20 Biolabs, Inc.
AIDXNasdaqCIK 1139685IndustrialsFiscal year ends Dec 31
Reports and events: 22 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2120:10 ET | DEF 14A | Proxy statementPeriod 2026-12-09 | 0001213900-26-111346 |
| 2026-09-1820:05 ET | 8-K | 5.07 Shareholder vote results | 0001213900-26-101405 |
| 2026-09-1020:10 ET | 8-K | 3.01 Delisting notice | 0001213900-26-098792 |
| 2026-09-0220:32 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-096743 |
| 2026-08-1913:19 ET | 8-K | 5.07 Shareholder vote results | 0001213900-26-091438 |
| 2026-08-1720:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-090746 |
| 2026-08-1420:07 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001213900-26-090042 |
| 2026-08-0516:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-085514 |
| 2026-07-2220:45 ET | 8-K | 1.01 Entry into a material agreement; 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001213900-26-080432 |
| 2026-07-0119:28 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-074182 |
| 2026-06-2321:02 ET | DEF 14A | Proxy statementPeriod 2026-08-18 | 0001213900-26-071172 |
| 2026-05-2620:28 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001213900-26-061039 |
| 2026-05-2020:18 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001213900-26-059542 |
| 2026-05-2020:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-059526 |
| 2026-04-2811:43 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-26-048257 |
| 2026-04-0621:28 ET | S-1 | Registration statement | 0001213900-26-040553 |
| 2026-04-0123:22 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-037770 |
| 2026-03-3121:26 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001213900-26-037667 |
| 2026-03-1021:14 ET | SCHEDULE 13D | Ownership report, active investor | 0001213900-26-025764 |
| 2026-01-2619:51 ET | S-1/A | Registration statement, amended | 0001213900-26-007650 |
| 2026-01-2121:50 ET | S-1/A | Registration statement, amended | 0001213900-26-006263 |
| 2025-12-1222:19 ET | S-1 | Registration statement | 0001213900-25-121285 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:05 ET. Listed shows no prices and gives no investment advice.